One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-139181
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 12 |
Affiliation: Rocky Mountain Cancer Centers, GlaxoSmithKline (United States), Hôpital Saint-Louis, Medical University of Silesia, Royal Marsden Hospital, Universität Hamburg, University Medical Center Hamburg-Eppendorf, Research Triangle Park Foundation, University of Catania, GlaxoSmithKline (United Kingdom), Alfred Health, Monash University, Samsung Medical Center, Sungkyunkwan University, University Hospital Ostrava, National and Kapodistrian University of Athens, Alexandra Hospital, São Germano Oncologia, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer
DREAMM-7: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin (Belamaf) with Bortezomib, and Dexamethasone (B-Vd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
